Skip to main content
  • LODESTAR Trial: ‘Treat-to-Target’ Statin Therapy Noninferior to High-Intensity Regimen in CAD Patients

    A strategy of using moderate statin therapy and adjusting until a target low-density lipoprotein cholesterol (LDL-C) level of 50 to 70 mg/dL was achieved was noninferior to a high-intensity statin regimen at 3 years in patients with coronary artery disease (CAD), new randomized trial results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details